Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 1
2007 2
2008 2
2009 3
2010 2
2011 2
2012 4
2013 4
2014 9
2015 2
2016 7
2017 11
2018 3
2019 3
2020 4
2021 10
2022 9
2023 13
2024 15
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

105 results

Results by year

Filters applied: . Clear all
Page 1
3D-MoRSE descriptors explained.
Devinyak O, Havrylyuk D, Lesyk R. Devinyak O, et al. Among authors: lesyk r. J Mol Graph Model. 2014 Nov;54:194-203. doi: 10.1016/j.jmgm.2014.10.006. Epub 2014 Nov 4. J Mol Graph Model. 2014. PMID: 25459771
Autophagy Modulators in Cancer Therapy.
Buzun K, Gornowicz A, Lesyk R, Bielawski K, Bielawska A. Buzun K, et al. Among authors: lesyk r. Int J Mol Sci. 2021 May 28;22(11):5804. doi: 10.3390/ijms22115804. Int J Mol Sci. 2021. PMID: 34071600 Free PMC article. Review.
Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms.
Pecquet C, Papadopoulos N, Balligand T, Chachoua I, Tisserand A, Vertenoeil G, Nédélec A, Vertommen D, Roy A, Marty C, Nivarthi H, Defour JP, El-Khoury M, Hug E, Majoros A, Xu E, Zagrijtschuk O, Fertig TE, Marta DS, Gisslinger H, Gisslinger B, Schalling M, Casetti I, Rumi E, Pietra D, Cavalloni C, Arcaini L, Cazzola M, Komatsu N, Kihara Y, Sunami Y, Edahiro Y, Araki M, Lesyk R, Buxhofer-Ausch V, Heibl S, Pasquier F, Havelange V, Plo I, Vainchenker W, Kralovics R, Constantinescu SN. Pecquet C, et al. Among authors: lesyk r. Blood. 2023 Feb 23;141(8):917-929. doi: 10.1182/blood.2022016846. Blood. 2023. PMID: 36356299 Free PMC article.
Anticancer 5-arylidene-2-(4-hydroxyphenyl)aminothiazol-4(5H)-ones as tubulin inhibitors.
Rehulka J, Subtelna I, Kryshchyshyn-Dylevych A, Cherniienko A, Ivanova A, Matveieva M, Polishchuk P, Gurska S, Hajduch M, Zagrijtschuk O, Dzubak P, Lesyk R. Rehulka J, et al. Among authors: lesyk r. Arch Pharm (Weinheim). 2022 Dec;355(12):e2200419. doi: 10.1002/ardp.202200419. Epub 2022 Sep 15. Arch Pharm (Weinheim). 2022. PMID: 36109178
4-Thiazolidinone-Bearing Hybrid Molecules in Anticancer Drug Design.
Roszczenko P, Holota S, Szewczyk OK, Dudchak R, Bielawski K, Bielawska A, Lesyk R. Roszczenko P, et al. Among authors: lesyk r. Int J Mol Sci. 2022 Oct 28;23(21):13135. doi: 10.3390/ijms232113135. Int J Mol Sci. 2022. PMID: 36361924 Free PMC article. Review.
In-vitro antiviral screening of some thiopyranothiazoles.
Kryshchyshyn-Dylevych A, Kaminskyy D, Lesyk R. Kryshchyshyn-Dylevych A, et al. Among authors: lesyk r. Chem Biol Interact. 2023 Dec 1;386:110738. doi: 10.1016/j.cbi.2023.110738. Epub 2023 Oct 8. Chem Biol Interact. 2023. PMID: 37816448
105 results